Table 2 Respiratory evolution of the Study Groups at Follow-Up according to gestational age.
From: Asthma prevalence, lung and cardiovascular function in adolescents born preterm
< 32 weeks N = 74 | ≥ 32 weeks N = 74 | Odds ratio Confidence Interval 95% | P value | |
|---|---|---|---|---|
Respiratory admissions | 34 (46%) | 21 (28%) | 2.1 (1.1–4.2) | 0.030 |
Respiratory ICU admissions | 9 (12%) | 2 (2.7%) | 4.5 (1.1–20.1) | 0.030 |
Montelukast | 58 (78%) | 57 (77%) | 1.1 (0.5–2.3) | 0.843 |
Inhaled corticosteroids | 35 (47%) | 16 (22%) | 3.3 (1.6–6.7) | 0.001 |
Allergic sensitization | 21 (54%) | 27 (40%) | 1.7 (0.8–2.3) | 0.177 |
Parental asthma | 16(12%) | 16 (12%) | 1.0 (0.4–2.4) | 1 |
Parental atopy | 30 (40.5%) | 23 (31%) | 1.5 (0.8–2.9) | 0.230 |
